Qube Research & Technologies (QRT)’s AbbVie ABBV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.6M	Sell	122,200 -88,400	-42%	-$19.6M	0.03%	716
2025 Q4	$48.1M	Sell	210,600 -52,600	-20%	-$12M	0.05%	511
2025 Q3	$60.9M	Sell	263,200 -133,300	-34%	-$27.1M	0.06%	386
2025 Q2	$73.6M	Buy	396,500 +345,200	+673%	+$64.2M	0.07%	342
2025 Q1	$10.7M	Sell	51,300 -92,000	-64%	-$17.9M	0.01%	1085
2024 Q4	$25.5M	Sell	143,300 -12,100	-8%	-$2.22M	0.03%	623
2024 Q3	$30.7M	Buy	155,400 +67,500	+77%	+$12.6M	0.05%	499
2024 Q2	$15.1M	Buy	87,900 +17,800	+25%	+$2.95M	0.02%	743
2024 Q1	$12.8M	Buy	70,100 +40,300	+135%	+$6.95M	0.02%	744
2023 Q4	$4.62M	Hold	29,800	–	–	0.01%	1076
2023 Q3	$4.44M	Buy	+29,800	New	+$4.37M	0.01%	987
2023 Q2	–	Sell	-50,000	Closed	-$7.97M	–	2333
2023 Q1	$7.97M	Buy	+50,000	New	+$7.64M	0.03%	536

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ABBV Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,093,561 shares — an estimated $243M sold.

Qube Research & Technologies (QRT) first reported a position in ABBV in Q1 2018 and held it in 25 quarters. The position peaked at $634M in Q2 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 1,093,561 AbbVie shares in Q1 2026, an estimated $243M.
Qube Research & Technologies (QRT) first reported a position in AbbVie in Q1 2018 and held it in 25 quarters.
Qube Research & Technologies (QRT)'s AbbVie position peaked at $634M in Q2 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.